Are Medical Stocks Lagging Lantheus (LNTH) This Year?

Company Overview - Lantheus Holdings (LNTH) is a notable stock within the Medical sector, currently ranked 6 in the Zacks Sector Rank, which evaluates 16 different sector groups [2] - The company has a Zacks Rank of 1 (Strong Buy), indicating a favorable earnings outlook based on earnings estimates and revisions [3] Performance Metrics - Lantheus Holdings has seen a year-to-date return of approximately 26.2%, significantly outperforming the Medical sector's average return of 4.3% [4] - Over the past quarter, the Zacks Consensus Estimate for LNTH's full-year earnings has increased by 13.8%, reflecting improved analyst sentiment [4] Industry Context - Lantheus Holdings operates within the Medical - Products industry, which consists of 91 companies and currently ranks 89 in the Zacks Industry Rank [6] - The Medical - Products industry has experienced an average gain of 3.5% year-to-date, indicating that LNTH is performing better than its industry peers [6] Comparative Analysis - Another Medical stock, Agios Pharmaceuticals (AGIO), has also outperformed the sector with a year-to-date increase of 41.5% and a Zacks Rank of 2 (Buy) [5] - The consensus EPS estimate for Agios Pharmaceuticals has risen by 12.4% over the past three months, showcasing a positive trend similar to that of Lantheus Holdings [5] Investment Consideration - Investors in the Medical sector may find Lantheus Holdings and Agios Pharmaceuticals to be strong candidates for continued solid performance [7]